{"id":509680,"date":"2020-10-03T16:54:01","date_gmt":"2020-10-03T16:54:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=509680"},"modified":"2020-10-03T16:54:01","modified_gmt":"2020-10-03T16:54:01","slug":"global-medical-information-market-anticipated-to-surge-at-a-cagr-of-74-through-2027-accenture-plc-infosys-limited-iqvia-c3i-solutions-cognizant","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-medical-information-market-anticipated-to-surge-at-a-cagr-of-74-through-2027-accenture-plc-infosys-limited-iqvia-c3i-solutions-cognizant_509680.html","title":{"rendered":"Global Medical Information Market Anticipated to Surge at a CAGR of 7.4% Through 2027 | Accenture plc, Infosys Limited, IQVIA, C3i Solutions, Cognizant"},"content":{"rendered":"
\"Global<\/a><\/p>\n
\n
Grand View Research, Inc. – Market Research And Consulting.<\/div>\n<\/div>\n<\/div>\n
Medical Information Market Size, Share & Trends Analysis Report By Service Provider (In House, Outsourcing), By Therapeutic Area, By Product Life Cycle, By Company Size, By End-use, By Region, And Segment Forecasts, 2020 – 2027<\/div>\n

The global medical information market<\/a><\/strong> size is expected to reach USD 3.66 Billion by 2027, according to a new report by Grand View Research, Inc. The market is projected to progress at a CAGR of 7.4% during the forecast period. Increasing demand for new drug development coupled with the emergence of technologically advanced healthcare solutions, timely accessible information pertinent to healthcare products is anticipated to fuel the market growth.<\/p>\n

Increasing healthcare expenditure and growing awareness about adverse drug events can increase the possibility of patients seeking medical information. Increase in adoption of social media for discussions on adverse events, ingredients, and other drug-related information.<\/p>\n

The market expansion is a result of an increased number of clinical trials and due to the high prevalence of chronic diseases. Moreover, manufacturers of health products are outsourcing MI services to Contract Research Organizations (CROs) to limit the accountability of stringent regulatory compliances by working with a well-established outsourcing partner company. This helps them in reducing operational costs, regulatory compliance risk, and minimizing process delays.<\/p>\n

The key factors attributing to the increased demand for outsourcing of medical information services are rising costs of pre-clinical research, drug development, clinical trials, and post-marketing surveillance. The healthcare sector is witnessing paradigm changes in the past decade, due to the depleting product pipeline, patent cliff, and regulatory constraints in new product development. This is expected to boost the adoption of contract outsourcing activities over the forecast period.<\/p>\n

Read More Info @ https:\/\/www.grandviewresearch.com\/industry-analysis\/medical-information-market\/request\/rs1
<\/a><\/strong><\/p>\n

Rising drug development cost, high investments needed for drug discovery, clinical research, and post-marketing surveillance are some of the key contributors to the market growth. The medical sector is witnessing paradigm shifts over the last decade, owing to an increasing number of patent cliffs, regulatory constraints, and the depleting product pipeline.<\/p>\n

\"The<\/p>\n

<\/strong><\/p>\n

Medical Information Market Report Highlights<\/strong><\/p>\n